Status:
UNKNOWN
Microbiome, Anxiety and Cognitive Orientation Study
Lead Sponsor:
Endominance
Collaborating Sponsors:
Dr. John J. Ratey
HEM Pharma Inc.
Conditions:
Anxiety
Microbiome
Eligibility:
All Genders
18+ years
Brief Summary
Mounting evidence shows that the gut microbiome plays an important role in communication within the gut-brain axis. However, the relationship between gut microbiota and their influence on anxiety is s...
Detailed Description
This study aims to expand and improve upon previous research on gut bacteria and their connections to anxiety. The Investigators will examine the gut microbiota and its vital role in the gut-brain axi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Participants must be 18 years of age and older
- Participants must be able to read and write English
- Participants must be able to provide consent independently
- Participants must provide a legitimate postal address/P.O Box
- Participants must have access to a device such as a computer or a smartphone
- Exclusion Criteria
- Unable to provide a stool sample due to health status or functional impairment
Exclusion
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2023
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05388630
Start Date
June 1 2022
End Date
May 30 2023
Last Update
December 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endominance Inc.
Irvine, California, United States, 92618